Literature DB >> 23928953

Where to for pelvic organ prolapse treatment after the FDA pronouncements? Comment.

H M P Pelikan1.   

Abstract

Mesh：

Year:  2013        PMID： 23928953     DOI： 10.1007/s00192-013-2187-7

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN： 0937-3462            Impact factor:   2.894


× No keyword cloud information.
  3 in total

1.  Long-term outcomes following abdominal sacrocolpopexy for pelvic organ prolapse.

Authors:  Ingrid Nygaard; Linda Brubaker; Halina M Zyczynski; Geoffrey Cundiff; Holly Richter; Marie Gantz; Paul Fine; Shawn Menefee; Beri Ridgeway; Anthony Visco; Lauren Klein Warren; Min Zhang; Susan Meikle
Journal:  JAMA       Date:  2013-05-15       Impact factor: 56.272

2.  Abdominal sacral colpopexy or vaginal sacrospinous colpopexy for vaginal vault prolapse: a prospective randomized study.

Authors:  Christopher F Maher; Aymen M Qatawneh; Peter L Dwyer; Marcus P Carey; Ann Cornish; Philip J Schluter
Journal:  Am J Obstet Gynecol       Date:  2004-01       Impact factor: 8.661

Review 3.  Where to for pelvic organ prolapse treatment after the FDA pronouncements? A systematic review of the recent literature.

Authors:  J M van Geelen; P L Dwyer
Journal:  Int Urogynecol J       Date:  2013-01-10       Impact factor: 2.894
  3 in total
  1 in total

1.  Where to for pelvic organ prolapse treatment after the FDA pronouncements? Reply to Pelikan.

Authors:  J M van Geelen; P L Dwyer
Journal:  Int Urogynecol J       Date:  2013-11       Impact factor: 2.894
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.